EXECUTIVE TRANSITION AGREEMENTExecutive Transition Agreement • January 8th, 2024 • Athira Pharma, Inc. • Biological products, (no disgnostic substances) • Washington
Contract Type FiledJanuary 8th, 2024 Company Industry JurisdictionTHIS EXECUTIVE TRANSITION AGREEMENT (this “Agreement”) is entered into as of January 5, 2024 (the “Effective Date”) between Athira Pharma, Inc. (the “Company”) and Hans Moebius (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).